Akamai Technologies Q1 2026 Earnings EPS Slightly Misses Estimates as Stock Edges Higher Exicure XCUR Q2 2022 Earnings WiderThanExpected Loss Fails to Deter Investors ProKidney Corp PROK Q1 2026 Earnings Narrowed Loss and Steady Progress in Kidney Disease Therapy Dermata Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss Supports Ongoing Clinical Development CNTN Q4 2023 Earnings EPS Surprises Positively Despite Revenue Absence Stock Declines 65 BRSP Q1 2026 Earnings EPS Misses Estimates Amid Challenging Market Conditions